S&P 500   3,856.70 (-1.75%)
DOW   31,589.30 (-1.17%)
QQQ   317.18 (-2.14%)
AAPL   122.92 (-1.94%)
MSFT   231.74 (-1.20%)
FB   258.52 (-2.19%)
GOOGL   2,034.48 (-2.37%)
AMZN   3,095.00 (-2.04%)
TSLA   700.42 (-5.61%)
NVDA   538.95 (-7.07%)
BABA   244.52 (-2.32%)
CGC   34.04 (-4.38%)
GE   12.88 (-1.83%)
MU   90.49 (-2.19%)
NIO   47.98 (-7.48%)
AMD   83.45 (-4.01%)
T   28.77 (-2.08%)
F   11.92 (-2.85%)
ACB   11.12 (-4.47%)
DIS   193.88 (-1.84%)
BA   220.73 (-3.75%)
NFLX   542.59 (-1.96%)
BAC   36.23 (-0.41%)
S&P 500   3,856.70 (-1.75%)
DOW   31,589.30 (-1.17%)
QQQ   317.18 (-2.14%)
AAPL   122.92 (-1.94%)
MSFT   231.74 (-1.20%)
FB   258.52 (-2.19%)
GOOGL   2,034.48 (-2.37%)
AMZN   3,095.00 (-2.04%)
TSLA   700.42 (-5.61%)
NVDA   538.95 (-7.07%)
BABA   244.52 (-2.32%)
CGC   34.04 (-4.38%)
GE   12.88 (-1.83%)
MU   90.49 (-2.19%)
NIO   47.98 (-7.48%)
AMD   83.45 (-4.01%)
T   28.77 (-2.08%)
F   11.92 (-2.85%)
ACB   11.12 (-4.47%)
DIS   193.88 (-1.84%)
BA   220.73 (-3.75%)
NFLX   542.59 (-1.96%)
BAC   36.23 (-0.41%)
S&P 500   3,856.70 (-1.75%)
DOW   31,589.30 (-1.17%)
QQQ   317.18 (-2.14%)
AAPL   122.92 (-1.94%)
MSFT   231.74 (-1.20%)
FB   258.52 (-2.19%)
GOOGL   2,034.48 (-2.37%)
AMZN   3,095.00 (-2.04%)
TSLA   700.42 (-5.61%)
NVDA   538.95 (-7.07%)
BABA   244.52 (-2.32%)
CGC   34.04 (-4.38%)
GE   12.88 (-1.83%)
MU   90.49 (-2.19%)
NIO   47.98 (-7.48%)
AMD   83.45 (-4.01%)
T   28.77 (-2.08%)
F   11.92 (-2.85%)
ACB   11.12 (-4.47%)
DIS   193.88 (-1.84%)
BA   220.73 (-3.75%)
NFLX   542.59 (-1.96%)
BAC   36.23 (-0.41%)
S&P 500   3,856.70 (-1.75%)
DOW   31,589.30 (-1.17%)
QQQ   317.18 (-2.14%)
AAPL   122.92 (-1.94%)
MSFT   231.74 (-1.20%)
FB   258.52 (-2.19%)
GOOGL   2,034.48 (-2.37%)
AMZN   3,095.00 (-2.04%)
TSLA   700.42 (-5.61%)
NVDA   538.95 (-7.07%)
BABA   244.52 (-2.32%)
CGC   34.04 (-4.38%)
GE   12.88 (-1.83%)
MU   90.49 (-2.19%)
NIO   47.98 (-7.48%)
AMD   83.45 (-4.01%)
T   28.77 (-2.08%)
F   11.92 (-2.85%)
ACB   11.12 (-4.47%)
DIS   193.88 (-1.84%)
BA   220.73 (-3.75%)
NFLX   542.59 (-1.96%)
BAC   36.23 (-0.41%)
Log in
NASDAQ:TMBR

Timber Pharmaceuticals Stock Forecast, Price & News

$1.98
-0.12 (-5.71 %)
(As of 02/25/2021 02:33 PM ET)
Add
Compare
Today's Range
$1.76
Now: $1.98
$2.15
50-Day Range
$0.81
MA: $1.46
$3.06
52-Week Range
$0.67
Now: $1.98
$10.44
Volume160,515 shs
Average Volume9.57 million shs
Market Capitalization$23.82 million
P/E RatioN/A
Dividend YieldN/A
Beta0.17
Timber Pharmaceuticals LLC, a clinical-stage medical dermatology company, focuses on the development and commercialization of pharmaceuticals for treatment of orphan dermatologic diseases. The company was founded in 2019 and is based in Woodcliff Lake, New Jersey.

Headlines

Timber Makes Way Up on New Hire
January 27, 2021 |  baystreet.ca
Timber Pharmaceuticals Hosts Business Update Conference Call
December 10, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TMBR
CUSIPN/A
CIKN/A
Phone973 314 9570
Employees3
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$60,000.00
Book Value($2.54) per share

Profitability

Miscellaneous

Market Cap$23.82 million
Next Earnings Date2/25/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.00 out of 5 stars

Medical Sector

983rd out of 1,957 stocks

Pharmaceutical Preparations Industry

467th out of 771 stocks

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$1.98
-0.12 (-5.71 %)
(As of 02/25/2021 02:33 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TMBR News and Ratings via Email

Sign-up to receive the latest news and ratings for TMBR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Timber Pharmaceuticals (NASDAQ:TMBR) Frequently Asked Questions

What stocks does MarketBeat like better than Timber Pharmaceuticals?

Wall Street analysts have given Timber Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Timber Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Timber Pharmaceuticals' next earnings date?

Timber Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for Timber Pharmaceuticals
.

Who are Timber Pharmaceuticals' key executives?

Timber Pharmaceuticals' management team includes the following people:
  • Mr. Michael Derby M.B.A., M.S., Exec. Chairman (Age 48)
  • Mr. John Koconis M.B.A., CEO & Director (Age 51)
  • Mr. Zachary Rome, Pres, COO, Exec. VP, Sec. & Director (Age 37)
  • Mr. Joseph Lucchese, Exec. VP & CFO (Age 54)
  • Dr. Amir Tavakkol, Chief Scientific Officer (Age 66)

Who are some of Timber Pharmaceuticals' key competitors?

What other stocks do shareholders of Timber Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Timber Pharmaceuticals investors own include Akorn (AKRXQ), Akers Biosciences (AKER), Akebia Therapeutics (AKBA), Adamis Pharmaceuticals (ADMP), ADMA Biologics (ADMA), Acasti Pharma (ACST), AcelRx Pharmaceuticals (ACRX), Acorda Therapeutics (ACOR), Aurora Cannabis Inc. (ACB.TO) (ACB) and Ambev (ABEV).

What is Timber Pharmaceuticals' stock symbol?

Timber Pharmaceuticals trades on the NASDAQ under the ticker symbol "TMBR."

How do I buy shares of Timber Pharmaceuticals?

Shares of TMBR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Timber Pharmaceuticals' stock price today?

One share of TMBR stock can currently be purchased for approximately $1.98.

How much money does Timber Pharmaceuticals make?

Timber Pharmaceuticals has a market capitalization of $23.82 million and generates $60,000.00 in revenue each year.

How many employees does Timber Pharmaceuticals have?

Timber Pharmaceuticals employs 3 workers across the globe.

What is Timber Pharmaceuticals' official website?

The official website for Timber Pharmaceuticals is www.timberpharma.com.

Where are Timber Pharmaceuticals' headquarters?

Timber Pharmaceuticals is headquartered at 50 TICE BLVD SUITE A26, WOODCLIFF LAKE NJ, 07677.

How can I contact Timber Pharmaceuticals?

Timber Pharmaceuticals' mailing address is 50 TICE BLVD SUITE A26, WOODCLIFF LAKE NJ, 07677. The company can be reached via phone at 973 314 9570 or via email at [email protected]


This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.